Anthropometric factors and risk of melanoma in women: A pooled analysis

International Journal of Cancer

Volumn 122, Issue 5, 2008, Pages 1100-1108

  Olsen, Catherine M ^a,b   Green, Adèle C ^a,b   Zens, Michael S ^c   Stukel, Therese A ^c,d   Bataille, Veronique ^e,f   Berwick, Marianne ^g   Elwood, J Mark ^h   Gallagher, Richard ^h   Holly, Elizabeth A ⁱ   Kirkpatrick, Connie ^j   Mack, Thomas ^k   Østerlind, Anne ^l   Rosso, Stefano ^m   Swerdlow, Anthony J ⁿ   Karagas, Margaret R ^c  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f Hemel Hempstead HP2 4AD   (United Kingdom)

^g UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Franciscan Health System   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l CPO Registro Tumori Piemonte ^*  (Denmark)

^m Registro Tumori Piemonte   (Italy)

ⁿ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

Anthropometry; Body mass index; Height; Melanoma; Weight

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; RISK FACTOR; SOCIOECONOMICS; SUN EXPOSURE; WEIGHT GAIN; ADOLESCENT; AGED; CASE CONTROL STUDY; MIDDLE AGED; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS;

EID: 38749101347     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23214     Document Type: Article

References (67)

1. Weight Control and Physical Activity. In: Vainio H, Bianchini F, eds. IARC handbooks of cancer prevention, vol. 6. Lyon: IARC, 2002. 83-199.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
3. Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR. Adult stature and risk of cancer. Cancer Res 1988;48:1658-62.
4. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565-74.
5. Cutler C, Foulkes WD, Brunet JS, Flanders TY, Shibata H, Narod SA. Cutaneous malignant melanoma in women is uncommonly associated with a family history of melanoma in first-degree relatives: a case-control study. Melanoma Res 1996;6:435-40.
6. Naldi L, Altieri A, Imberti GL, Giordano L, Gallus S, La Vecchia C. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Ann Epidemiol 2005;15:545-50.
7. Gallus S, Naldi L, Martin L, Martinelli M, La Vecchia C. Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res 2006;16:83-7.
8. Smith MA, Fine JA, Barnhill RL, Berwick M. Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 1998;27:751-7.
9. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995;141:923-33.
10. Shors AR, Solomon C, McTiernan A, White E. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control 2001;12:599-606.
11. Kirkpatrick CS, White E, Lee JA. Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 1994;139:869-80.
12. Bain C, Green A, Siskind V, Alexander J, Harvey P. Diet and melanoma. An exploratory case-control study. Ann Epidemiol 1993;3:235-8.
13. Green A, McCredie M, MacKie R, Giles G, Young P, Morton C, Jackman L, Thursfield V. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999;10:21-5.
14. Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer 1985;52:901-7.
15. Holman CD, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984;50:673-80.
16. Le Marchand L, Saltzman BS, Hankin JH, Wilkens LR, Franke AA, Morris SJ, Kolonel LN. Sun exposure, diet, and melanoma in Hawaii Caucasians. Am J Epidemiol 2006;164:232-45.
17. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
18. Thune I, Olsen A, Albrektsen G, Tretli S. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway. Int J Cancer 1993;55:555-61.
19. Veierod MB, Thelle DS, Laake P. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 1997;71:600-4.
20. Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 2003;14:847-57.
21. Veierod MB, Weiderpass E, Thorn M, Hansson J, Lund E, Armstrong B, Adami HO. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 2003;95:1530-8.
22. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30A:344-50.
23. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, Adam HO. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001;12:13-21.
24. Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006;118:458-66.
25. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 1995;141:934-42.
26. Holly EA, Cress RD, Ahn DK. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 1995;141:943-50.
27. Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A, Mack T, Kirkpatrick C, Holly EA, Green A, Gallagher R, Elwood JM, et al. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 2006;17:11-19.
28. Lambe M, Thorn M, Sparen P, Bergstrom R, Adami HO. Malignant melanoma: reduced risk associated with early childbearing and multi-parity. Melanoma Res 1996;6:147-53.
29. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N. Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 1996;73:1126-31.
30. Holly EA, Weiss NS, Liff JM. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 1983;70:827-31.
31. Lea CS, Holly EA, Hartge P, Lee JS, Guerry Dt, Elder DE, Halpern A, Sagebiel RW, Tucker MA. Reproductive risk factors for cutaneous melanoma in women: a case-control study. Am J Epidemiol 2007;165:505-13.
32. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
33. Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med 2001;20:2115-30.
34. Karagas MR, Stukel TA, Dykes J, Miglionico J, Greene MA, Carey M, Armstrong B, Elwood JM, Gallagher RP, Green A, Holly EA, Kirkpatrick CS, et al. A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer 2002;86:1085-92.
35. Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977;36:804-9.
36. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996;73:1605-11.
37. Green A, Bain C. Hormonal factors and melanoma in women. Med J Aust 1985;142:446-8.
38. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 1988;42:821-4.
39. Zanetti R, Franceschi S, Rosso S, Bidoli E, Colonna S. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol 1990;19:522-6.
40. Young people's health - a challenge for society. Report of a WHO Study Group on young people and "Health for All by the Year 2000." World Health Organ Tech Rep Ser 1986;731:1-117.
41. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
42. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;317:1098.
43. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. The international melanoma analysis group (IMAGE). Int J Cancer 1995;62:367-76.
44. Ford D, Bliss JM, Swerdlow AJ, Armstrong BK, Franceschi S, Green A, Holly EA, Mack T, MacKie RM, Osterlind A. Risk of cutaneous melanoma associated with a family history of the disease. The international melanoma analysis group (IMAGE). Int J Cancer 1995;62:377-81.
45. Odenbro A, Gillgren P, Bellocco R, Boffetta P, Hakansson N, Adami J. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol 2007;156:99-105.
46. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF, Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006;17:901-9.
47. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10:15-32.
48. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
49. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, et al. Body size and risk of colon and rectal cancer in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
50. Engeland A, Tretli S, Austad G, Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control 2005;16:987-96.
51. Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 1988;80:772-4.
52. Ross MH, Bras G. Tumor incidence patterns and nutrition in the rat. J Nutr 1965;87:245-60.
53. Ross MH, Bras G. Lasting influence of early caloric restriction on prevalence of neoplasms in the rat. J Natl Cancer Inst 1971;47:1095-113.
54. Frankel S, Gunnell DJ, Peters TJ, Maynard M, Davey Smith G. Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. BMJ 1998;316:499-504.
55. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NE. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-42.
56. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42:3232-9.
57. Norton K, Olds T. Morphological evolution of athletes over the 20th century: causes and consequences. Sports Med 2001;31:763-83.
58. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-62.
59. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349-64.
60. Osterlind A, Engholm G, Jensen OM. Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site. APMIS 1988;96:953-63.
61. MacKie RM, Bray CA, Hole DJ, Morris A, Nicolson M, Evans A, Doherty V, Vestey J. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002;360:587-91.
62. Chen YT, Zheng T, Holford TR, Berwick M, Dubrow R. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 1994;5:341-50.
63. Quesenberry CP, Jr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998;158:466-72.
64. Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord 1995;19:570-2.
65. Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S. The predictive validity of body mass index based on self-reported weight and height. Int J Obes 1989;13:441-53.
66. Lawlor DA, Bedford C, Taylor M, Ebrahim S. Agreement between measured and self-reported weight in older women. Results from the British Women's Heart and Health Study. Age Ageing 2002;31:169-74.
67. Taylor AW, Dal Grande E, Gill TK, Chittleborough CR, Wilson DH, Adams RJ, Grant JF, Phillips P, Appleton S, Ruffin RE. How valid are self-reported height and weight? A comparison between CATI self-report and clinic measurements using a large cohort study. Aust N Z J Public Health 2006;30:238-46.